Deputy Solicitor General Nirmalan Wigneswaran made the announcement during a hearing on a Fundamental Rights petition filed in connection with the case. The petition challenges the procurement of drugs from two unregistered Indian pharmaceutical companies under the Indian credit line and lists Rambukwella and others as respondents.
